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Numerous factors are involved in the eradication of misfolded proteins, yet how these 
factors achieve substrate specificity remains unclear. In this issue of Cell, Denic et al. (2006) 
and Carvalho et al. (2006) report that two distinct protein complexes at the endoplasmic 
reticulum membrane are responsible for the recognition and degradation of specific subsets 
of protein substrates.Everyone has experienced the frus-
tration of purchasing defective mer-
chandise. Most often, the fault lies not 
in design but in production. Manu-
facturing good products depends on 
the level of quality control in the fac-
tory that makes them. When properly 
deployed, quality-control inspectors 
monitor each manufacturing step 
and take defective products out of 
the assembly line to be repaired or 
recycled. Ineffective controls are det-
rimental to the company’s long-term 
viability. In biology, living cells are 
literally little factories that churn out 
thousands of new molecules of vary-
ing shapes, sizes, and complexity 
every minute. Similarly, their survival 
depends on efficient quality-control 
mechanisms that ensure molecules 
are correctly synthesized.
In protein quality control, the first 
step is recognition. The system must 
be able to distinguish between mol-
ecules that are actively folding, fully 
folded, and misfolded. Accurate 
discrimination of the three forms is 
essential in the endoplasmic retic-
ulum (ER) because each form is 
handled differently. Actively folding 
proteins are retained in the ER and 
shielded from degradation path-
ways, folded proteins destined for 
export are packaged into transport 
vesicles, and misfolded proteins are 
retained and sorted for degradation. 
Once the determination is made, 
misfolded proteins are targeted to 
processing sites on the ER mem-
brane for their extraction through a conduit whose identity is still 
unknown. When at least part of the 
substrate is exposed to the cytosol, 
E2 ubiquitin-conjugating enzymes 
and E3 ligases attach polyubiquitin 
tags to the protein, thus condemn-
ing it for destruction. The substrates 
are fully extracted from the mem-
branes by the Cdc48p AAA-ATPase 
complex and degraded by the 26S 
proteasome in the cytosol (for 
review, see Romisch, 2005). These 
terminal steps of ER quality control 
have been termed ER-associated 
degradation or ERAD. In this issue 
of Cell, Carvalho et al. (2006) and 
Denic et al. (2006) shed light on the 
specificity of this degradation path-
way by demonstrating that distinct 
protein complexes form sites of rec-
ognition, ubiquitination, and extrac-
tion for specific substrate classes.
Proteins transiting the ER can be 
soluble or membrane bound with 
significant portions in the lumen, 
membrane, and cytosol. To accom-
modate the topological diversity, 
distinct pathways work side by side 
to monitor misfolding. Substrates 
are targeted to an appropriate ERAD 
pathway depending on the site of 
the misfolded lesion. Membrane and 
soluble proteins with luminal lesions 
are targeted to the ERAD-L pathway 
whereas membrane proteins with 
misfolded cytoplasmic domains use 
the ERAD-C pathway (Vashist and 
Ng, 2004). Although ERAD-L and 
ERAD-C can be defined by distinct 
factors, how these factors are phys-Cell 126ically arranged as part of a system 
to carry out ERAD was unknown. 
To clarify this problem, Carvalho 
et al. (2006) applied a biochemi-
cal approach to understand the 
organization of protein complexes 
associated with the E3 ubiquitin 
ligases Hrd1p and Doa10p, which 
define the ERAD-L and ERAD-C 
pathways, respectively. Denic et al. 
(2006) chose a similar approach 
but focused on a key player of the 
ERAD-L pathway, Yos9p.
Both studies were performed in 
budding yeast due to the availability 
of mutant strains and well-character-
ized ERAD substrates. As most com-
ponents of ERAD are evolutionarily 
conserved, the basic conclusions 
derived from these studies are likely 
to be applicable to all eukaryotes. 
Carvalho et al. (2006) engineered 
tandem affinity purification (TAP) 
tags into Hrd1p and Doa10p. The 
resulting proteins and their part-
ners were purified and identified by 
mass spectrometry. Reassuringly, 
nearly all the partner proteins found 
were already known to be involved in 
ERAD. What was interesting was the 
composition of each complex (Figure 
1). The Doa10p complex is relatively 
simple. Aside from Doa10p (the E3 
ligase), it contains an E2 complex 
(Ubc7p and its membrane-anchor-
ing factor Cue1p) and the Cdc48p 
complex (the AAA-ATPase Cdc48p, 
its cofactors Ufd1 and Npl4, and 
its membrane anchorage protein 
Ubx2p). With the bulk of the protein , July 28, 2006 ©2006 Elsevier Inc. 237
domains in the cytosol, the 
organization of the Doa10p 
complex supports its pur-
ported role in recognizing and 
ubiquitinating substrates with 
misfolded cytosolic domains. 
Most notably, the absence of 
Hrd1p in this complex indi-
cates that distinct processing 
complexes define the ERAD 
pathways.
The Hrd1p complex used 
by the ERAD-L pathway is 
more complicated as might 
be expected. Hrd1p was pre-
viously shown to form a 1:1 
complex with Hrd3p, an ERAD 
factor with a large ER luminal 
domain (Gardner et al., 2000). 
Hrd3p copurified with TAP-
tagged Hrd1p as anticipated. 
The Ubc7p/Cue1p dimer and 
the Cdc48p complex, part-
ners of Doa10p, were also 
found in complex with Hrd1p. 
However, this is where the 
similarities end. Additional 
factors that are unique to the 
complex, including Der1p, 
Yos9p, and Usa1p, were puri-
fied (Figure 1). Der1p is a small 
protein that spans the ER 
membrane four times. It was 
one of the first ERAD factors 
identified and it comes in direct con-
tact with substrates, yet its function 
remains unclear (Knop et al., 1996). 
Yos9p is a luminal lectin-like protein 
that specifically binds misfolded 
glycoproteins in ERAD (reviewed in 
Cormier et al., 2005), and Usa1p is 
a new factor with a large cytosolic 
domain and two transmembrane seg-
ments. Analysis of pathway-specific 
substrates showed that, like Der1p 
and Yos9p, Usa1p is a component of 
the ERAD-L pathway. Its role is inte-
gral as it is needed to link Der1p to 
the Hrd1p ligase. Interestingly, pro-
teins with disrupted transmembrane 
domains degrade independently of 
these factors, but require only Hrd1p 
and Hrd3p. For this, the authors pro-
posed a new pathway termed ERAD-
M. Whether ERAD-M substrates 
require additional factors for their 
recognition, as ERAD-L substrates 
do, is uncertain.
Native purification of Yos9p by 
Denic et al. (2006) yielded the same 
complex of proteins as TAP-tagged 
Hrd1p and two additional factors, 
Emp47p and Kar2p. Emp47p is an 
interesting protein because it plays 
roles in vesicular transport. This 
may be relevant to some ERAD-L 
substrates that can traffic between 
the ER and Golgi. The chaperone 
Kar2p (also known as BiP) binds 
substrates and keeps them soluble 
for ERAD (Nishikawa et al., 2001). 
The new data indicate that Kar2p 
associates directly with Yos9p, 
independently of its peptide bind-
ing activity. Although the signifi-
cance of this interaction is unclear, 
the arrangement of Yos9p within 
the ERAD-L complex has provided 
important clues (Figure 1). Previous 
studies have suggested that Yos9p 
may function as a substrate recep-
tor, based on its ability to discrimi-
nate between folded and mis-
folded proteins (reviewed in 
Cormier et al., 2005). Hrd3p 
can also interact with mis-
folded substrates (Denic et 
al., 2006; Gauss et al., 2006). 
Denic et al. (2006) found that 
Yos9p binds directly to the 
luminal domain of Hrd3p. 
Given that Kar2p, Yos9p, and 
Hrd3p can bind substrates 
independently, this particu-
lar luminal region of the com-
plex may serve as the recep-
tor site for ERAD substrates.
Surprisingly, overexpression 
of Hrd1p partially bypassed 
the requirement for Kar2p 
and Yos9p. Yet, the absence 
of Hrd3p and Yos9p results in 
promiscuous protein degrada-
tion, indicative of a breakdown 
in ERAD substrate selection. 
This suggests that Yos9p and 
Hrd3p play crucial roles as 
“gatekeepers” in recognizing 
substrates to be degraded. 
The mechanism for discrimi-
nation appears to rely on sub-
strate determinants that are 
bipartite. Yos9p and Hrd3p 
can bind and sample unfolded 
proteins independently of their 
attached carbohydrate groups 
(Denic et al., 2006; Gauss et al., 2006). 
However, acceptance of the substrate 
for ERAD requires the additional pres-
ence of a site-specific glycan group 
processed by α-mannosidase I. The 
slow enzymatic activity of the enzyme 
has been proposed to serve as a timer 
for folding (Jakob et al., 1998), indicat-
ing that “misfolded” proteins might 
look similar to actively folding proteins, 
except that they have exceeded their 
allotted time to fold. Unfolded proteins 
bearing the resulting GlcNac2-Man8 
glycan structure are deemed misfolded 
after inspection by Yos9p/Hrd3p and 
degraded.
Together, these studies bring us 
closer to a unified view of ER qual-
ity control that can account for 
the diversity of proteins that traf-
fic through the organelle. We now 
know that distinct protein com-
plexes in the ER membrane func-
tion to receive and inspect unfolded 
Figure 1. Two Distinct Membrane Protein Complexes 
Define ERAD Pathways
(Top) The Doa10p complex of the ERAD-C pathway. (Bottom) 
The Hrd1p complex of the ERAD-L pathway. Yos9 recognizes 
sugar modifications on misfolded proteins. In both panels, 
substrates are represented in gray with lesion sites marked by 
stars. The figure is an adaptation of the models presented in 
Carvalho et al. (2006) and Denic et al. (2006).238 Cell 126, July 28, 2006 ©2006 Elsevier Inc.
proteins. The E3 ubiquitin ligases 
Hrd1p and Doa10p organize factors 
used for the recognition, ubiquitina-
tion, and extraction of substrates. 
Indeed, Hrd1p provides the direct 
physical link between recognition 
events in the ER lumen and ubiq-
uitination and extraction activi-
ties in the cytosol (Carvalho et al., 
2006; Denic et al., 2006; Gauss et 
al., 2006). However, many pressing 
questions remain. Left out of the 
discussion is a second nonredun-
dant lectin, Htm1p (EDEM in mam-
mals), which is crucial in ERAD-L. 
Also, how substrates are moved to 
the cytosol remains elusive. The 
identity of the dislocation pore in 
ERAD-L remains controversial and Removal of errors from newly syn-
thesized DNA by the mismatch repair 
(MMR) machinery increases the fidel-
ity of the replication process by up to 
three orders of magnitude. Moreover, 
the inactivation of genes involved in 
MMR by mutation or epigenetic silenc-
ing leads to a substantial increase in 
mutation frequency, and in mammals, 
loss of MMR promotes cancer of the 
colon and other organs (Jiricny, 2006). 
Given the importance of the MMR sys-
tem in the maintenance of genomic 
stability, the study of the molecular 
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The mismatch repair process c
and colleagues (Kadyrov et al
machinery, MutLα, has endon
the mismatch and thus gene
the strand containing the miswhether such a conduit is even 
needed in ERAD-C and ERAD-M 
is unknown. Unlike the Hrd1p com-
plex, there are no clear ideas on 
how the Doa10p complex partici-
pates in selecting substrates. There 
is no doubt, however, that the cru-
cial framework these new studies 
provides will accelerate the resolu-
tion of these and other mysteries of 
how molecular inspectors carry out 
their work in ER quality control.
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